118 related articles for article (PubMed ID: 33689058)
21. Trends and variations in treatment of stage I-III non-small cell lung cancer from 2008 to 2018: A nationwide population-based study from the Netherlands.
Evers J; de Jaeger K; Hendriks LEL; van der Sangen M; Terhaard C; Siesling S; De Ruysscher D; Struikmans H; Aarts MJ
Lung Cancer; 2021 May; 155():103-113. PubMed ID: 33774382
[TBL] [Abstract][Full Text] [Related]
22. Tumor subtypes and survival in male breast cancer.
Leone J; Freedman RA; Lin NU; Tolaney SM; Vallejo CT; Leone BA; Winer EP; Leone JP
Breast Cancer Res Treat; 2021 Aug; 188(3):695-702. PubMed ID: 33770314
[TBL] [Abstract][Full Text] [Related]
23. Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies.
Prat A; Chaudhury A; Solovieff N; Paré L; Martinez D; Chic N; Martínez-Sáez O; Brasó-Maristany F; Lteif A; Taran T; Babbar N; Su F
J Clin Oncol; 2021 May; 39(13):1458-1467. PubMed ID: 33769862
[TBL] [Abstract][Full Text] [Related]
24. Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D).
Moreno-Aspitia A; Holmes EM; Jackisch C; de Azambuja E; Boyle F; Hillman DW; Korde L; Fumagalli D; Izquierdo MA; McCullough AE; Wolff AC; Pritchard KI; Untch M; Guillaume S; Ewer MS; Shao Z; Sim SH; Aziz Z; Demetriou G; Mehta AO; Andersson M; Toi M; Lang I; Xu B; Smith IE; Barrios CH; Baselga J; Gelber RD; Piccart-Gebhart M;
Eur J Cancer; 2021 May; 148():287-296. PubMed ID: 33765513
[TBL] [Abstract][Full Text] [Related]
25. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity.
Miglioretti DL; Bissell MCS; Kerlikowske K; Buist DSM; Cummings SR; Henderson LM; Onega T; O'Meara ES; Rauscher GH; Sprague BL; Tosteson ANA; Wernli KJ; Lee JM; Lee CI
JAMA Netw Open; 2021 Mar; 4(3):e211974. PubMed ID: 33764423
[TBL] [Abstract][Full Text] [Related]
26. Detection of clustered circulating tumour cells in early breast cancer.
Krol I; Schwab FD; Carbone R; Ritter M; Picocci S; De Marni ML; Stepien G; Franchi GM; Zanardi A; Rissoglio MD; Covelli A; Guidi G; Scarinci D; Castro-Giner F; Mazzarella L; Doglioni C; Borghi F; Milani P; Kurzeder C; Weber WP; Aceto N
Br J Cancer; 2021 Jul; 125(1):23-27. PubMed ID: 33762721
[TBL] [Abstract][Full Text] [Related]
27. Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
Galardi F; De Luca F; Biagioni C; Migliaccio I; Curigliano G; Minisini AM; Bonechi M; Moretti E; Risi E; McCartney A; Benelli M; Romagnoli D; Cappadona S; Gabellini S; Guarducci C; Conti V; Biganzoli L; Di Leo A; Malorni L
Breast Cancer Res; 2021 Mar; 23(1):38. PubMed ID: 33761970
[TBL] [Abstract][Full Text] [Related]
28. Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials.
Villegas SL; Nekljudova V; Pfarr N; Engel J; Untch M; Schrodi S; Holms F; Ulmer HU; Fasching PA; Weber KE; Albig C; Heinrichs C; Marmé F; Hartmann A; Hanusch C; Schmitt WD; Huober J; Lederer B; van Mackelenbergh M; Tesch H; Jackisch C; Rezai M; Sinn P; Sinn BV; Hackmann J; Kiechle M; Schneeweiss A; Weichert W; Denkert C; Loibl S
Eur J Cancer; 2021 May; 148():159-170. PubMed ID: 33743484
[TBL] [Abstract][Full Text] [Related]
29. Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer.
Quintana Á; Peg V; Prat A; Moliné T; Villacampa G; Paré L; Galván P; Dientsmann R; Schmid P; Curigliano G; Muñoz-Couselo E; Perez-García J; Marti M; Blanco-Heredia J; Anjos CD; Vazquez M; De Mattos-Arruda L; Cortés J
Eur J Cancer; 2021 May; 148():134-145. PubMed ID: 33743482
[TBL] [Abstract][Full Text] [Related]
30. A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006).
Gharzai LA; Szczygiel LA; Shumway DA; Bandos H; Julian TB; Mamounas EP; White J; De Los Santos JF; Basik M; Ganz PA; Jagsi R
Breast Cancer Res Treat; 2021 Jun; 187(3):777-784. PubMed ID: 33740205
[TBL] [Abstract][Full Text] [Related]
31. A propensity score-matched comparison of recurrence outcomes after immediate implant vs autologous flap reconstruction in patients receiving neoadjuvant chemotherapy for breast cancer.
Wu ZY; Han HH; Kim HJ; Lee JW; Chung IY; Kim J; Lee SB; Son BH; Eom JS; Jung JH; Kim SB; Gong G; Kim HH; Ahn S-; Ko B
Breast Cancer Res Treat; 2021 Jun; 187(2):417-425. PubMed ID: 33740204
[TBL] [Abstract][Full Text] [Related]
32. Effect of centralization and regionalization of pancreatic surgery on resection rates and survival.
Latenstein AEJ; Mackay TM; van der Geest LGM; van Eijck CHJ; de Meijer VE; Stommel MWJ; Vissers PAJ; Besselink MG; de Hingh IHJT;
Br J Surg; 2021 Jul; 108(7):826-833. PubMed ID: 33738473
[TBL] [Abstract][Full Text] [Related]
33. Genetic testing and surgical treatment after breast cancer diagnosis: Results from a national online cohort.
Verdial FC; Bartek MA; Anderson BO; Javid SH
J Surg Oncol; 2021 Jun; 123(7):1504-1512. PubMed ID: 33735483
[TBL] [Abstract][Full Text] [Related]
34. Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial.
Eriksson M; Eklund M; Borgquist S; Hellgren R; Margolin S; Thoren L; Rosendahl A; Lång K; Tapia J; Bäcklund M; Discacciati A; Crippa A; Gabrielson M; Hammarström M; Wengström Y; Czene K; Hall P
J Clin Oncol; 2021 Jun; 39(17):1899-1908. PubMed ID: 33734864
[TBL] [Abstract][Full Text] [Related]
35. Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer: comparison of diagnostic performances of dedicated breast PET, whole-body PET, and dynamic contrast-enhanced MRI.
Tokuda Y; Yanagawa M; Fujita Y; Honma K; Tanei T; Shimoda M; Miyake T; Naoi Y; Kim SJ; Shimazu K; Hamada S; Tomiyama N
Breast Cancer Res Treat; 2021 Jul; 188(1):107-115. PubMed ID: 33730265
[TBL] [Abstract][Full Text] [Related]
36. Self-perceived cognitive functioning and quality of life among cancer survivors: results from the PROFILES registry.
Oerlemans S; Schagen SB; van den Hurk CJ; Husson O; Schoormans D; van de Poll-Franse LV
J Cancer Surviv; 2022 Apr; 16(2):303-313. PubMed ID: 33728574
[TBL] [Abstract][Full Text] [Related]
37. Beyond Teenage and Young Adult Cancer Care: Care Experiences of Patients Aged 25-39 Years Old in the UK National Health Service.
Lidington E; Darlington AS; Vlooswijk C; Beardsworth S; McCaffrey S; Tang S; Stallard K; Younger E; Edwards P; Ali AI; Nandhabalan M; Din A; Starling N; Larkin J; Stanway S; Nobbenhuis M; Banerjee S; Szucs Z; Gonzalez M; Sirohi B; Husson O; van der Graaf WTA
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):494-506. PubMed ID: 33722412
[TBL] [Abstract][Full Text] [Related]
38. Validation and comparison of Breast Graded Prognostic Assessment scores in patients with breast cancer and brain metastases.
Fabregat-Franco C; Stradella A; Navarro V; Linares J; Galdeano M; Recalde S; Velasco R; Simo M; Fernadez A; Venthecourt AC; Falo C; Vazquez S; Bergamino M; Villanueva R; Pernas S; Gil-Gil MJ
Clin Transl Oncol; 2021 Sep; 23(9):1761-1768. PubMed ID: 33704689
[TBL] [Abstract][Full Text] [Related]
39. RE: Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early stage breast cancer patients.
Li XM; Chen HL
Breast Cancer Res Treat; 2021 Apr; 186(2):585-586. PubMed ID: 33704617
[No Abstract] [Full Text] [Related]
40. Are Breast Cancer Nomograms Still Valid to Predict the Need for Axillary Dissection?
Madekivi V; Karlsson A; Boström P; Salminen E
Oncology; 2021; 99(6):397-401. PubMed ID: 33691330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
